A Leading Immunology Healthcare Company | Sanofi
WEBSeptember 25, 2024. Media Update: EADV: New data reinforce Sanofi’s innovative approach and leadership across immune-mediated skin diseases. Read the Press Release. See all press releases. Sanofi …
Our Company, pioneering pharmaceutical innovations
WEBIn an uncertain and fast-moving environment, we hold ourselves to the highest standards. Code of Conduct. Sanofi, a global healthcare pharmaceutical company, is dedicated to improving lives through …
Sanofi Vaccines: Protecting Lives at Every Stage | Sanofi
Latest Sanofi Press Releases and News | Sanofi
WEBSep 20, 2024 · Press Release: Sanofi Q2 - strong performance with 10% sales growth; 2024 guidance upgraded. Read the Press Release. July 17, 2024.
Sanofi Careers: Explore Job Opportunities
Our Science - Sanofi
WEBWe chase the miracles of science, working across disciplines to solve problems, take smart risks, and discover the extraordinary. We’re determined to find answers for patients, and to develop medicines and …
Sanofi Investor Relations: Creating Trust and Value
WEBTo contact the Investor Relations team: 46 avenue de la Grande Armée. 75017 Paris FRANCE. investor.relations (at) sanofi.com. Contact us. Stay informed with Sanofi's investor relations for insights on our strategy, …
Sanofi Medicine: Leading Speciality Healthcare | Sanofi
WEBGeneral Medicine Focus Areas. Explore Sanofi's medicines for general and specialty healthcare, including immunology, neurology, oncology, and rare diseases.
Improving Lives With Healthcare Solutions | Sanofi
WEBOur standard-of-care medicines help people manage their health and help relieve pressure on healthcare systems. For generations, we’ve been delivering medicines for people living with diabetes and cardiovascular …
Our Commitment to Oncology - Advancing Cancer …
WEBEuropean Commission (2022). EU Science Hub. European Cancer Information System: 21% increase in new cancer cases by 2040. Accessed October 2022. Discover Sanofi's oncology commitment, delivering …
